TLPPF News and Press, Telix Pharmaceuticals Ltd From 02/12/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

China Grand Pharma announced a $340 million agreement to develop and commercialize Telix Pharma's molecularly-targeted radiation products in China. JW Therapeutics, a Shanghai cell therapy company, raised $300 million in its Hong Kong IPO at a market capitalization of $1 billion. ...

Telix Pharmaceuticals Limited ( OTC:TLPPF ) will collaborate with Varian Medical Systems (NYSE: VAR ) to evaluate the use of advanced prostate cancer imaging within Varian's radiation treatment planning platform. More news on: Telix Pharmaceuticals Limited, Varian Medical Systems, In...

Telix Pharmaceuticals ( OTC:TLPPF ) has entered into a collaboration agreement with the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) in the field of image-guided surgery for prostate cancer. More news on: Telix Pharmaceuticals Limited, Healthcare stocks news, ...